Results from a preclinical study in mice and a collaborative clinical study in patients show that the type 2 immune response -- associated with parasitic infection and thought to play a negative role ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

In a new development, General Motors and its Chinese partner CATL have unveiled the fastest-charging EV battery to date.

In 2012, 7-year-old Emily Whitehead became the first pediatric patient to receive pioneering chimeric antigen receptor (CAR-T ...